These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 23756685)

  • 21. Changing epidemiology of systemic fungal infections.
    Richardson M; Lass-Flörl C
    Clin Microbiol Infect; 2008 May; 14 Suppl 4():5-24. PubMed ID: 18430126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lignoren, a new sesquiterpenoid metabolite from Trichoderma lignorum HKI 0257.
    Berg A; Wangun HV; Nkengfack AE; Schlegel B
    J Basic Microbiol; 2004; 44(4):317-9. PubMed ID: 15266604
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial metabolites from a bacterial symbiont.
    Li J; Chen G; Webster JM; Czyzewska E
    J Nat Prod; 1995 Jul; 58(7):1081-6. PubMed ID: 7561900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, synthesis, and biological evaluation of novel 1, 2, 4-triazole derivatives as antifungal agent.
    Chai X; Yu S; Jiang Y; Zou Y; Wu Q; Zhang D; Jiang Y; Cao Y; Sun Q
    Arch Pharm Res; 2012 Nov; 35(11):1895-901. PubMed ID: 23212630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Mechanistic Targets of Antifungal Agents: An Overview.
    Mazu TK; Bricker BA; Flores-Rozas H; Ablordeppey SY
    Mini Rev Med Chem; 2016; 16(7):555-78. PubMed ID: 26776224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New approaches to antifungal chemotherapy.
    Viviani MA; de Marie S; Graybill JR; Yamaguchi H; Anaissie E; Caillot D
    Med Mycol; 1998; 36 Suppl 1():194-206. PubMed ID: 9988508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isolation and activity of Xenorhabdus antimicrobial compounds against the plant pathogens Erwinia amylovora and Phytophthora nicotianae.
    Böszörményi E; Ersek T; Fodor A; Fodor AM; Földes LS; Hevesi M; Hogan JS; Katona Z; Klein MG; Kormány A; Pekár S; Szentirmai A; Sztaricskai F; Taylor RA
    J Appl Microbiol; 2009 Sep; 107(3):746-59. PubMed ID: 19320949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnosis of invasive fungal infections in immunocompromised children.
    Dornbusch HJ; Groll A; Walsh TJ
    Clin Microbiol Infect; 2010 Sep; 16(9):1328-34. PubMed ID: 20678175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Identification of filamentous fungi isolated from clinical samples by two different methods and their susceptibility results].
    Direkel S; Otağ F; Aslan G; Ulger M; Emekdaş G
    Mikrobiyol Bul; 2012 Jan; 46(1):65-78. PubMed ID: 22399173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance.
    Fera MT; La Camera E; De Sarro A
    Expert Rev Anti Infect Ther; 2009 Oct; 7(8):981-98. PubMed ID: 19803707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antifungal activity of a new triazole, voriconazole (UK-109,496), compared with three other antifungal agents tested against clinical isolates of filamentous fungi.
    Marco F; Pfaller MA; Messer SA; Jones RN
    Med Mycol; 1998 Dec; 36(6):433-6. PubMed ID: 10206756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Xenorhabdus antibiotics: a comparative analysis and potential utility for controlling mastitis caused by bacteria.
    Furgani G; Böszörményi E; Fodor A; Máthé-Fodor A; Forst S; Hogan JS; Katona Z; Klein MG; Stackebrandt E; Szentirmai A; Sztaricskai F; Wolf SL
    J Appl Microbiol; 2008 Mar; 104(3):745-58. PubMed ID: 17976177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Metabolites produced by bacteria of Xenorhabdus and Photorhabdus].
    Wang L; Yang X; Jian H; Yang H; Huang D
    Wei Sheng Wu Xue Bao; 2001 Dec; 41(6):753-6. PubMed ID: 12552836
    [No Abstract]   [Full Text] [Related]  

  • 34. In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi.
    Espinel-Ingroff A
    J Clin Microbiol; 2001 Mar; 39(3):954-8. PubMed ID: 11230410
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antifungal sensitivity testing for equine keratomycosis.
    Coad CT; Robinson NM; Wilhelmus KR
    Am J Vet Res; 1985 Mar; 46(3):676-8. PubMed ID: 3994133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fungal spectrum identified by a new slide culture and in vitro drug susceptibility using Etest in fungal keratitis.
    Qiu WY; Yao YF; Zhu YF; Zhang YM; Zhou P; Jin YQ; Zhang B
    Curr Eye Res; 2005 Dec; 30(12):1113-20. PubMed ID: 16354625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Candidiasis, aspergillosis and other invasive mycoses in recipients of solid organ transplants].
    Quindós G
    Rev Iberoam Micol; 2011; 28(3):110-9. PubMed ID: 21700230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antifungal activity of flocculosin, a novel glycolipid isolated from Pseudozyma flocculosa.
    Mimee B; Labbé C; Pelletier R; Bélanger RR
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1597-9. PubMed ID: 15793149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antimycotic sensitivity of clinically important yeasts and moulds in the agar diffusion method (author's transl)].
    Dermoumi H
    Mykosen; 1982 Mar; 25(3):109-17. PubMed ID: 7088025
    [No Abstract]   [Full Text] [Related]  

  • 40. Role of symbiotic and non-symbiotic bacteria in carbon dioxide production from hosts infected with Steinernema riobrave.
    Christen JM; Campbell JF; Zurek L; Shapiro-Ilan DI; Lewis EE; Ramaswamy SB
    J Invertebr Pathol; 2008 Sep; 99(1):35-42. PubMed ID: 18621386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.